Morphological remodeling in atrial fibrillation;Morphologisches remodeling bei vorhofflimmern

Herz

Volumn 31, Issue 2, 2006, Pages 101-107

  Goette, Andreas ^a   Lendeckel, Uwe ^b  

^a Klinik fur Kardiologie Angiologie und Pneumologie   (Germany)

^b Institut für Experimentelle Innere Medizin   (Germany)

Author keywords

Atrial fibrillation; Calcium; Fibrosis; Gene therapy; Pathology

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCINEURIN; CALCIUM CHANNEL L TYPE; CALPAIN; PHOSPHATASE; PROTEINASE;

ANTIARRHYTHMIC ACTIVITY; ARTICLE; CALCIUM CURRENT; CELL ULTRASTRUCTURE; DRUG EFFICACY; ELECTRIC CONDUCTIVITY; ELECTROPHYSIOLOGY; FIBROSIS; GENE TRANSFER; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; HYPERTENSION; PATHOPHYSIOLOGY;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FUNCTION; CALCIUM; CARDIOMEGALY; DOWN-REGULATION; FIBROSIS; GENE THERAPY; HEART ATRIA; HUMANS; MYOCARDIUM; OXIDATIVE STRESS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; SIGNAL TRANSDUCTION;

EID: 33745130057     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-006-2788-8     Document Type: Article

References (38)

1. Kannel WB, Abbott RD, Savage DD, et al. Epidemiological features of atrial fibrillation: the Framingham Study. N Engl J Med 1982;306:1018-22.
2. Murgatroyd FD, Camm AJ. Atrial arrhythmias. Lancet 1993;341:1317-22.
3. Furberg CD, Psaty BM, Manolio TA, et al. Prevalence of of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 1994;74:236-41.
4. Wijffels MCEF, Kirchhof CJHJ, Dorland R, et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995;92:1954-68.
5. Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation: time course and mechanisms. Circulation 1996;94:2968-74.
6. Ausma J, Wijffels M, Thone F, et al. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 1997;96:3157-63.
7. Schotten U, Ausma J, Stellbrink C, et al. Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation. Circulation 2001;103:691-8.
8. Goette A, Arndt M, Röcken C, et al. Calpains and cytokines in fibrillating human atria. Am J Physiol Heart Circ Physiol 2002;283:H264-72.
9. Goette A, Lendeckel U. Non-channel drug targets in atrial fibrillation. Pharmacol Ther 2004;102:17-36.
10. Lendeckel U, Müller C, Röcken C, et al. Expression of opioid receptor subtypes and their ligands in fibrillating human atria. PACE 2005;28:S1-5.
11. Carnes CA, Chung MK, Nakayama T, et al. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res 2001;89:e32-8.
12. Mihm MJ, Yu F, Carnes CA, et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 2001;104:174-80.
13. Bukowska A, Lendeckel U, Hirte D, et al. Activation of the calcineurin signaling pathway induces atrial hypertrophy during atrial fibrillation. J Cell Mol Life Sci 2006:63:333-42.
14. Unverferth DV, Fertel RH, Unverferth BJ, et al. Atrial fibrillation in mitral stenosis: histologic, hemodynamic and metabolic factors. Int J Cardiol 1984;5:143-54.
15. Nitta T, Imura H, Bessho R, et al. Wavelength and conduction inhomogeneity in each atrium in patients with isolated mitral valve disease and atrial fibrillation. J Cardiovasc Electrophysiol 1999;10:521-8.
16. Goette A, Juenemann G, Peters B, et al. Determinants and consequences of atrial fibrosis in patients undergoing open heart surgery. Cardiovasc Res 2002;54:390-6.
17. Li D, Fareh S, Leung TK, et al. Promotion of atrial fibrillation by heart failure in dogs: electrical remodeling of a different sort. Circulation 1999:100:87-95.
18. Goette A, Staack T, Röcken C, et al. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol 2000;35:1669-77.
19. Goette A, Arndt M, Röcken C, et al. Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans. Circulation 2000;101:2678-81.
20. Kannel WB, Wolf PA, Benjamin EJ, et al. Prevalence, incidence, prognosis and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998;82:Suppl:2N-9N.
21. Healey JS, Connolly ST. Atrial fibrillation: hypertension as a causative agent, risk factor for complications, and potential therapeutic target. Am J Cardiol 2003;91:Suppl:9G-14G.
22. Madrid AH, Bueno MG, Rebollo JM, et al. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study. Circulation 2002;106:331-6.
23. Xu J, Cui G, Esmailian F, et al. Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation. Circulation 2004;109:363-8.
24. Goette A, Röcken C, Nepple K, et al. Proteases and arrhythmias. In: Hooper NM, Lendeckel U, eds. Proteases in biology and disease. Vol 1: Proteases in tissue remodeling of lung and heart. New York-Boston-Dordrecht-London-Moscow: Kluwer Academic/Plenum Publishers, 2003:191-218.
25. Anne W, Willems R, Roskams T, et al. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation. Cardiovasc Res 2005;67:655-66.
26. Arndt M, Lendeckel U, Röcken C, et al. Altered expression of ADAMs (a disintegrin and metalloproteinase) in fibrillating human atria. Circulation 2002;105:720-5.
27. Röcken C, Peters B, Juenemann G, et al. Atrial amyloidosis: an arrhythmogenic substrate for persistent atrial fibrillation. Circulation 2002;106:2091-7.
28. Goette A, Röcken C. Atrial amyloidosis and atrial fibrillation: a gender-dependent "arrhythmogenic substrate"? Eur Heart J 2004;25:1185-6.
29. Kizana E, Ginn SL, Allen DG, et al. Fibroblasts can be genetically modified to produce excitable cells capable of electrical coupling. Circulation 2005;111:394-8.
30. Gaudesius G, Miragoli M, Thomas SP, et al. Coupling of cardiac electrical activity over extended distances by fibroblasts of cardiac origin. Circ Res 2003;93:421-8.
31. Kikuchi K, McDonald AD, Sasano T, et al. Targeted modification of atrial electrophysiology by homogeneous transmural atrial gene transfer. Circulation 2005;111:264-70.
32. Goette A, Honeycutt C, Hartung W, et al. Direkte subendokardiale Katheterinfusionen als neues Ablationsverfahren von rechtsatrialen Arrhythmien. Herzschr Elektrophys 1997;8:129-36.
33. Bauer A, McDonald AD, Nasir K, et al. Inhibitory G protein overexpression provides physiologically relevant heart rate control in persistent atrial fibrillation. Circulation 2001;110:3115-20.
34. Quaini F, Urbanek K, Beltrami A, et al. Chimerism of the transplanted heart. N Engl J Med 2002;346:5-15.
35. Goette A, Jentsch-Ullrich K, Lendeckel U, et al. Effect of persistent atrial fibrillation and electrical cardioversion on haematopoietic progenitor cells. Circulation 2003;108:2446-9.
36. Goette A, Jentsch-Ullrich K, Hammwöhner M, et al. Cardiac uptake of progenitor cells in patients with moderate-to-severe left ventricular failure. Europace 2006:in press.
37. Zimmermann WH, Eschenhagen T. Questioning the relevance of circulating cardiac progenitor cells in cardiac regeneration. Cardiovsc Res 2005;68:344-6.
38. Ausoni S, Zaglia T, Dedja A, et al. Host-derived circulating cells do not significantly contribute to cardiac regeneration in heterotopic rat heart transplants. Cardiovasc Res 2005;68:394-404.